PedAM
Pediatric Disease Annotations & Medicines
| Disease | colorectal cancer |
| Phenotype | C0008311|cholangitis |
| Sentences | 6 |
| PubMedID- 22221173 | Conclusions: long-term high dose ursodeoxycholic acid does not prevent colorectal cancer or dysplasia in patients with primary sclerosing cholangitis-associated inflammatory bowel disease. |
| PubMedID- 26061393 | Background: histomorphology of colitis-associated colorectal cancer (cac) in patients with primary sclerosing cholangitis (psc) remains to be systemically characterized and prognosis in these patient needs to be further defined. |
| PubMedID- 23665966 | We performed a systematic review and meta-analysis of studies evaluating the effect of udca on the risk of ibd-associated colorectal neoplasia (crn) (defined as colorectal cancer and/or dysplasia) in patients with primary sclerosing cholangitis with concomitant ibd (psc-ibd). |
| PubMedID- 25636976 | colorectal cancer and cholangiocarcinoma in patients with primary sclerosing cholangitis and inflammatory bowel disease. |
| PubMedID- 23663396 | Apart from subgroups with early onset, extensive and long-standing inflammation, or primary sclerosing cholangitis the risk of developing colorectal cancer is of the same magnitude as in the background population. |
| PubMedID- 25350705 | Apart from subgroups with early onset, extensive and long-standing inflammation, or primary sclerosing cholangitis the risk of developing colorectal cancer is of the same magnitude as in the background population. |
Page: 1